About this trial
The purpose of this study is to investigate the relationship between alexithymia levels and clinical parameters, including pain intensity and quality of life, in chronic pain patients treated with spinal cord stimulation (SCS). Chronic neuropathic pain can lead to psychological distress and decreased quality of life. While SCS is an effective neuromodulation therapy for managing refractory pain, patient outcomes vary significantly, suggesting that biomedically similar patients experience different levels of relief due to psychosocial factors.
Alexithymia, characterized by difficulties in identifying and describing emotions, may significantly influence the individual pain experience and treatment outcomes. In this cross-sectional observational study, patients who underwent SCS implantation for clinical indications will be evaluated. Clinical data regarding pain history will be collected retrospectively from patient files, while psychosocial profiles will be assessed at a single time point using validated psychometric questionnaires. The study aims to contribute to a better understanding of psychosocial variables in neuromodulation outcomes, potentially aiding in improved patient selection and expectation management.
Eligibility criteria
Qualifiers
- Being 18 years of age or older
Having undergone permanent spinal cord stimulation (SCS) implantation due to clinical indications
Providing written informed consent for study participation
Being literate
Disqualifiers
Cognitive impairment or communication barriers that compromise the capacity to provide informed consent
Presence of active psychotic disorders or manic episodes
Suspected self-harm or suicide risk during the clinical interview
Presence of specific secondary causes that could explain the pain (e.g., active malignancy, active infection, acute fracture)
Trial design
Treatments tested in this trial
- Psychometric Questionnaires and Retrospective Data Collection